Found 1 publication.
Displayed publication 1
Expand all publications
Collapse all publications
Show all as text (SweetDB notation)
Show all graphically (SNFG notation)
1. (Article ID: 3905)
Moskowitz SM, Ernst RK
The Role of Pseudomonas Lipopolysaccharide in Cystic Fibrosis Airway Infection
Book: Endotoxins: Structure, Function and Recognition (series: Subcellular Biochemistry) (2010)
241-253
Pseudomonas aeruginosa (PA) is a ubiquitous environmental Gram-negative bacterium found in soil and water. This opportunistic pathogen can cause infections in individuals with impaired phagocytic function, such as those with burns, exposure to chemotherapy, or cystic fibrosis (CF). PA infects the lungs of most individuals with CF, and is associated with severe progressive pulmonary disease that is the major cause of premature death in this disorder. The specific adaptations of PA to the CF airway responsible for bacterial persistence and antibiotic tolerance are not completely understood but may include increased alginate production (i.e., mucoid phenotype), biofilm formation, and specific lipid A modifications. During adaptation to the CF airway, PA synthesizes a variety of lipid A structures that alter host innate immune responses and promote bacterial persistence and chronic infection. The synthesis of specific lipid A structures is attributable to bacterial enzymes that: (1) remove the 3OH-C10:0 acyl chain from the 3-position (PagL); (2) add a C16:0 acyl chain to the 3OH-C10:0 chain at the 3'-position (PagP); (3) add C12:0 and 2OH-C12:0 acyl chains to the 3OH-C12:0 chains at the 2- and 2'-positions (HtrB and LpxO); and (4) add aminoarabinose to phosphate groups at the 1- and 4'-positions (PmrH, PmrF, PmrI, PmrJ, PmrK, and PmrE). These lipid A modifications represent an essential aspect of PA adaptation to the CF airway.
Lipopolysaccharide, Pseudomonas aeruginosa, lipid A, inflammation, cystic fibrosis, innate immunity, antibiotic resistance, chronic infection
NCBI PubMed ID: 20593270Publication DOI: 10.1007/978-90-481-9078-2_11Publisher: Springer.
Editors: Wang X, Quinn PJ
Correspondence: rkernst

umaryland.edu
Institutions: Department of Microbial Pathogenesis, School of Dentistry, University of Maryland - Baltimore, 650 W. Baltimore Street - 8 South, Baltimore, MD, 21201, USA
The publication contains the following compound(s):
- Compound ID: 9115
|
3HODco-(1-3)-+ 3HOLau-(1-2)-+
| |
3HOLau-(1-2)-b-D-GlcpN-(1-6)-a-D-GlcpN-(1-P
| |
P-4)-+ 3HODco-(1-3)-+ |
Show graphically |
Structure type: oligomer
; 1237
Compound class: lipid A
- Compound ID: 9116
|
3HODco-(1-3)-+ 3HOLau-(1-2)-+
| |
Lau-(1-3)-3HOLau-(1-2)-b-D-GlcpN-(1-6)-a-D-GlcpN-(1-P
| |
P-4)-+ 3HODco-(1-3)-+ |
Show graphically |
Structure type: oligomer
; 1419
Compound class: lipid A
- Compound ID: 9117
|
2HOLau-(1-3)-3HOLau-(1-2)-+
|
3HODco-(1-3)-+ |
| |
Lau-(1-3)-3HOLau-(1-2)-b-D-GlcpN-(1-6)-a-D-GlcpN-(1-P
| |
P-4)-+ 3HODco-(1-3)-+ |
Show graphically |
Structure type: oligomer
; 1617
Compound class: lipid A
- Compound ID: 9118
|
2HOLau-(1-3)-3HOLau-(1-2)-+
|
Pam-(1-3)-3HODco-(1-3)-+ |
| |
Lau-(1-3)-3HOLau-(1-2)-b-D-GlcpN-(1-6)-a-D-GlcpN-(1-P
| |
P-4)-+ 3HODco-(1-3)-+ |
Show graphically |
Structure type: oligomer
; 1855
Compound class: lipid A
- Compound ID: 9119
|
2HOLau-(1-3)-3HOLau-(1-2)-+
|
3HODco-(1-3)-+ |
| |
Lau-(1-3)-3HOLau-(1-2)-b-D-GlcpN-(1-6)-a-D-GlcpN-(1-P
|
P-4)-+ |
Show graphically |
Structure type: oligomer
; 1447
Compound class: lipid A
- Compound ID: 9120
|
2HOLau-(1-3)-3HOLau-(1-2)-+
|
Pam-(1-3)-3HODco-(1-3)-+ |
| |
Lau-(1-3)-3HOLau-(1-2)-b-D-GlcpN-(1-6)-a-D-GlcpN-(1-P
|
P-4)-+ |
Show graphically |
Structure type: oligomer
; 1685
Compound class: lipid A
Expand this publication
Collapse this publication
Total list of publication IDs on all result pages of the current query:
Total list of corresponding CSDB IDs (permanent record IDs):
Execution: 3 sec